These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 18829545)
1. Dual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesis. Kang YK; Schiff R; Ko L; Wang T; Tsai SY; Tsai MJ; O'Malley BW Cancer Res; 2008 Oct; 68(19):7887-96. PubMed ID: 18829545 [TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of RRM-containing coactivator activator (CoAA) as TRBP-interacting protein, and its splice variant as a coactivator modulator (CoAM). Iwasaki T; Chin WW; Ko L J Biol Chem; 2001 Sep; 276(36):33375-83. PubMed ID: 11443112 [TBL] [Abstract][Full Text] [Related]
3. Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation. Yang Z; Sui Y; Xiong S; Liour SS; Phillips AC; Ko L Nucleic Acids Res; 2007; 35(6):1919-32. PubMed ID: 17337438 [TBL] [Abstract][Full Text] [Related]
6. Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc. Liu Y; Yin B; Zhang C; Zhou L; Fan J Biochem Biophys Res Commun; 2012 Jan; 417(1):371-5. PubMed ID: 22155254 [TBL] [Abstract][Full Text] [Related]
7. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126 [TBL] [Abstract][Full Text] [Related]
8. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706 [TBL] [Abstract][Full Text] [Related]
9. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells]. Li CY; Yao AM; Chang XN; Guo YH; Xu R Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma. Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190 [TBL] [Abstract][Full Text] [Related]
12. Gene amplification and associated loss of 5' regulatory sequences of CoAA in human cancers. Sui Y; Yang Z; Xiong S; Zhang L; Blanchard KL; Peiper SC; Dynan WS; Tuan D; Ko L Oncogene; 2007 Feb; 26(6):822-35. PubMed ID: 16878147 [TBL] [Abstract][Full Text] [Related]
13. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression. Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573 [TBL] [Abstract][Full Text] [Related]
14. Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: a probable critical role in neoplastic transformation. Li JJ; Hou X; Banerjee SK; Liao DZ; Maggouta F; Norris JS; Li SA Cancer Res; 1999 May; 59(10):2340-6. PubMed ID: 10344741 [TBL] [Abstract][Full Text] [Related]
15. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression. Li X; Bian Y; Takizawa Y; Hashimoto T; Ikoma T; Tanaka J; Kitamura N; Inagaki Y; Komada M; Tanaka T Mol Cancer Res; 2013 Nov; 11(11):1437-47. PubMed ID: 24177224 [TBL] [Abstract][Full Text] [Related]
16. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix. Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772 [TBL] [Abstract][Full Text] [Related]
17. Functional pre- mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation. Brooks YS; Wang G; Yang Z; Smith KK; Bieberich E; Ko L J Biol Chem; 2009 Jul; 284(27):18033-46. PubMed ID: 19416963 [TBL] [Abstract][Full Text] [Related]
18. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells. Wang S; Raven JF; Koromilas AE Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011 [TBL] [Abstract][Full Text] [Related]
19. RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation. Chen P; Duan Y; Lu X; Chen L; Zhang W; Wang H; Hu R; Liu S Cancer Immunol Immunother; 2021 Nov; 70(11):3261-3275. PubMed ID: 33837850 [TBL] [Abstract][Full Text] [Related]
20. CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing. Auboeuf D; Dowhan DH; Li X; Larkin K; Ko L; Berget SM; O'Malley BW Mol Cell Biol; 2004 Jan; 24(1):442-53. PubMed ID: 14673176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]